Gatifloxacin
Links shared publicly online about this topic
Allergan Receives FDA Approval for Zymaxid Ophthalmic Solution
drugs.com — “Zymaxid (gatifloxacin ophthalmic solution) is used to treat bacterial conjunctivitis. Includes Zymaxid side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 19, 2010 at 11:38 pm By:
Allergan Receives FDA Approval for Zymaxid Ophthalmic Solution - http://bit.ly/dndI0j
Infectious Disease Article | Conjunctivitis
mdlinx.com — “Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis” View full resource at mdlinx.com
Most Recently Shared on April 19, 2011 at 12:37 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis: Clinical Ophthalmology http://bit.ly/dI1FE2 #ID
Gastroenterology Article | Fever
mdlinx.com — “Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial” View full resource at mdlinx.com
Most Recently Shared on May 28, 2011 at 5:15 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled t... http://bit.ly/kCSVcA #GI
New Antibiotic For Treating Typhoid In Low Income Countries Recommended Following Clinical Trial
medicalnewstoday.com — “A large clinical trial comparing treatments for typhoid has recommended the use of gatifloxacin, a new generation and affordable antibiotic. The results of the trial in Kathmandu, Nepal, funded by” View full resource at medicalnewstoday.com
Most Recently Shared on April 29, 2011 at 12:05 pm By:
New Antibiotic For Treating Typhoid In Low Income Countries Recommended Following Clinical Trial http://mnt.to/3Vc6 #diabetes
Family Medicine Article | Fever
mdlinx.com — “Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial” View full resource at mdlinx.com
Most Recently Shared on May 29, 2011 at 6:56 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, con... http://bit.ly/ki4P5V #FamPractice
Infectious Disease Article | Fever
mdlinx.com — “Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial” View full resource at mdlinx.com
Most Recently Shared on May 27, 2011 at 1:19 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled t... http://bit.ly/jdTz1f #ID
Infectious Disease Article | Mycoplasma genitalium
mdlinx.com — “Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial” View full resource at mdlinx.com
Most Recently Shared on May 9, 2011 at 6:13 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial: Sexually Tr... http://bit.ly/kIbYGC #ID
Study backs new drug for typhoid in poor countries | Reuters
reuters.com — “LONDON (Reuters) - A large trial comparing treatments for typhoid has backed the use of gatifloxacin, an antibiotic launched by Bristol Myers Squibb in the United States but withdrawn amid worries about” View full resource at reuters.com
Most Recently Shared on April 28, 2011 at 11:20 pm By:
Study backs new drug for typhoid in poor countries http://reut.rs/kD2xNX
Study backs new drug for typhoid in poor countries | Reuters
reuters.com — “LONDON (Reuters) - A large trial comparing treatments for typhoid has backed the use of gatifloxacin, an antibiotic launched by Bristol Myers Squibb in the United States but withdrawn amid worries about” View full resource at reuters.com
Most Recently Shared on April 29, 2011 at 1:05 am By:
HealthIT Policy Health IT and Health News
Study backs new drug for typhoid in poor countries: LONDON (Reuters) - A large trial comparing treatments for ty... http://bit.ly/kcX8GB
ZYMAXID - New Product Releases - MPR
empr.com — “Susceptible bacterial conjunctivitis.” View full resource at empr.com
Most Recently Shared on July 2, 2010 at 2:14 pm By:
MPR News: ZYMAXID: Gatifloxacin 0.5%; oph soln; contains benzalkonium chloride. http://bit.ly/aJKwyj
FDA approves eye drop solution for pink eye - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA approved Allergan's gatifloxacin 0.5% ophthalmic solution for treatment of pink eye in patients 1 year and older. Study data showed gatifloxacin was better than a nonmedicated treatment for achieving complete clearance of conjunctival hyperaemia and discharge and eradicating all baseline bac” View full resource at smartbrief.com
Most Recently Shared on May 25, 2010 at 4:47 pm By:
Clara Song Doctor, Pediatrician, and Physician
FDA approves eye drop solution for pink eye http://sbne.ws/r/4MrQ
Zymaxid ophthalmic solution approved for bacterial conjunctivitis - MPR
empr.com — “The FDA has approved Allergan's Zymaxid (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone, for the treatment of bacterial conjunctivitis caused by susceptible organisms.” View full resource at empr.com
Most Recently Shared on May 20, 2010 at 2:46 pm By:
MPR News: Zymaxid ophthalmic solution approved for bacterial conjunctivitis: The FDA has approved Allergan's Zymax... http://bit.ly/clFJJU
Zymaxid ophthalmic solution approved for bacterial conjunctivitis - MPR
empr.com — “The FDA has approved Allergan's Zymaxid (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone, for the treatment of bacterial conjunctivitis caused by susceptible organisms.” View full resource at empr.com
Most Recently Shared on May 20, 2010 at 3:23 pm By:
Zymaxid ophthalmic solution approved for bacterial conjunctivitis: The FDA has approved Allergan's Zymaxid (gatifl... http://bit.ly/cjMmKJ
Zymaxid ophthalmic solution approved for bacterial conjunctivitis - ONA
oncologynurseadvisor.com — “The FDA has approved Allergan--™s Zymaxid (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone, for the treatment of bacterial conjunctivitis caused by susceptible organisms.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 20, 2010 at 3:23 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Zymaxid ophthalmic solution approved for bacterial conjunctivitis http://goo.gl/fb/sDmLT
FDA approves ZYMAXID ophthalmic solution for treatment of bacterial conjunctivitis
news-medical.net — “Allergan, Inc. today announced that the United States Food and Drug Administration has approved ZYMAXID (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms; Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group, Streptococcus oralis, Streptococcus pneumonia.” View full resource at news-medical.net
Most Recently Shared on May 20, 2010 at 8:27 am By:
Obesity News: FDA approves ZYMAXID ophthalmic solution for treatment of bacterial conjunctivitis: Allergan, Inc.... http://twurl.nl/fcuc3y
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
